Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach

In COVID-19, pulmonary edema has been attributed to “cytokine storm”. However, it is known that SARS-CoV2 promotes angiotensin-converting enzyme 2 deficit, increases angiotensin II, and this triggers volume overload. Our report is based on COVID-19 patients with tomographic evidence of pulmonary ede...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Jose L. Francisco, Zanardi, Patricio, Alo, Veronica, Rodriguez, Marcelo, Magdaleno, Federico, De Langhe, Virginia, Dos Santos, Vanina, Murialdo, Giuliana, Villoldo, Andrea, Coria, Micaela, Quiros, Diego, Milicchio, Claudio, Garcia Saiz, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658626/
https://www.ncbi.nlm.nih.gov/pubmed/34884300
http://dx.doi.org/10.3390/jcm10235599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658626/
https://www.ncbi.nlm.nih.gov/pubmed/34884300
http://dx.doi.org/10.3390/jcm10235599

Ejemplares similares